Therefore, it is necessary to study the incidence and mechanism of an adverse prognosis of persistent avascular retina after anti-VEGF therapy in ROP patients based on FFA of the peripheral retina, including the ora serrata region, in order to shape the treatment strategy and provide evidence for the indications of prophylactic photocoagulation. The gene discussed is VEGFA; the disease is retinopathy of prematurity.